학술논문
Effectiveness and safety of initiating adalimumab plus >= 12 mg/week methotrexate with adjustable dosing in biologic-naive patients with early rheumatoid arthritis: HAWK study postmarketing surveillance in Japan
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
14397609